These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38085235)

  • 41. Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II.
    Chkioua L; Khedhiri S; Ferchichi S; Tcheng R; Chahed H; Froissart R; Vianey-Saban C; Laradi S; Miled A
    Diagn Pathol; 2011 May; 6():42. PubMed ID: 21605424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetics and Gene Therapy in Hunter Disease.
    Sestito S; Falvo F; Scozzafava C; Apa R; Pensabene L; Bonapace G; Moricca MT; Concolino D
    Curr Gene Ther; 2018; 18(2):90-95. PubMed ID: 29618310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of four mutations on the expression of iduronate-2-sulfatase in mucopolysaccharidosis type II.
    Bonuccelli G; Di Natale P; Corsolini F; Villani G; Regis S; Filocamo M
    Biochim Biophys Acta; 2001 Nov; 1537(3):233-8. PubMed ID: 11731225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.
    Hong J; Cheng YS; Yang S; Swaroop M; Xu M; Beers J; Zou J; Huang W; Marugan JJ; Cai X; Zheng W
    Exp Cell Res; 2022 Mar; 412(1):113007. PubMed ID: 34990619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel CRISPR/Cas9-based iduronate-2-sulfatase (IDS) knockout human neuronal cell line reveals earliest pathological changes.
    Badenetti L; Manzoli R; Trevisan M; D'Avanzo F; Tomanin R; Moro E
    Sci Rep; 2023 Jun; 13(1):10289. PubMed ID: 37357221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.
    Wilson PJ; Morris CP; Anson DS; Occhiodoro T; Bielicki J; Clements PR; Hopwood JJ
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8531-5. PubMed ID: 2122463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and structure characterization of novel IDS variants causing mucopolysaccharidosis type II: A retrospective analysis of 30 Chinese children.
    Zhao XY; Qiao GM; Liu F
    Clin Chim Acta; 2021 Dec; 523():386-394. PubMed ID: 34670126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy.
    Ellison S; Liao A; Gleitz HFE; Parker H; Booth L; Robinson J; Wood S; Taylor J; Holley R; Bigger BW
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101127. PubMed ID: 37920237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sequence of the human iduronate 2-sulfatase (IDS) gene.
    Wilson PJ; Meaney CA; Hopwood JJ; Morris CP
    Genomics; 1993 Sep; 17(3):773-5. PubMed ID: 8244397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic analysis of 63 Chinese patients with mucopolysaccharidosis type II: Functional characterization of seven novel IDS variants.
    Zhang W; Xie T; Sheng H; Shao Y; Lin Y; Jiang M; Xu A; Su X; Liu Z; Zhao X; Liu L; Huang Y
    Clin Chim Acta; 2019 Apr; 491():114-120. PubMed ID: 30639582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoplasmic Reticulum and Lysosomal Quality Control of Four Nonsense Mutants of Iduronate 2-Sulfatase Linked to Hunter's Syndrome.
    Marazza A; Galli C; Fasana E; Sgrignani J; Burda P; Fassi EMA; Baumgartner M; Cavalli A; Molinari M
    DNA Cell Biol; 2020 Feb; 39(2):226-234. PubMed ID: 31895584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of donor chimerism to reduce the level of glycosaminoglycans following bone marrow transplantation in a murine model of mucopolysaccharidosis type II.
    Yokoi K; Akiyama K; Kaneshiro E; Higuchi T; Shimada Y; Kobayashi H; Akiyama M; Otsu M; Nakauchi H; Ohashi T; Ida H
    J Inherit Metab Dis; 2015 Mar; 38(2):333-40. PubMed ID: 25503568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II.
    Sonoda H; Morimoto H; Yoden E; Koshimura Y; Kinoshita M; Golovina G; Takagi H; Yamamoto R; Minami K; Mizoguchi A; Tachibana K; Hirato T; Takahashi K
    Mol Ther; 2018 May; 26(5):1366-1374. PubMed ID: 29606503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction.
    Podetz-Pedersen KM; Laoharawee K; Singh S; Nguyen TT; Smith MC; Temme A; Kozarsky K; McIvor RS; Belur LR
    Hum Gene Ther; 2023 Jan; 34(1-2):8-18. PubMed ID: 36541357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of systemic high dose enzyme replacement therapy on the improvement of CNS defects in a mouse model of mucopolysaccharidosis type II.
    Cho SY; Lee J; Ko AR; Kwak MJ; Kim S; Sohn YB; Park SW; Jin DK
    Orphanet J Rare Dis; 2015 Oct; 10():141. PubMed ID: 26520066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "Supercharged Cells" for delivery of recombinant human iduronate-2-sulfatase.
    Pan D; Jonsson JJ; Braun SE; McIvor RS; Whitley CB
    Mol Genet Metab; 2000 Jul; 70(3):170-8. PubMed ID: 10924271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homologous nonallelic recombinations between the iduronate-sulfatase gene and pseudogene cause various intragenic deletions and inversions in patients with mucopolysaccharidosis type II.
    Bunge S; Rathmann M; Steglich C; Bondeson ML; Tylki-Szymanska A; Popowska E; Gal A
    Eur J Hum Genet; 1998; 6(5):492-500. PubMed ID: 9801874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Anti-Iduronate 2-Sulfatase Antibodies in Patients with Mucopolysaccharidosis Type II Treated with Enzyme Replacement Therapy.
    Vollebregt AAM; Hoogeveen-Westerveld M; Ruijter GJ; van den Hout H; Oussoren E; van der Ploeg AT; Pijnappel WWMP
    J Pediatr; 2022 Sep; 248():100-107.e3. PubMed ID: 35568060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production of therapeutic iduronate-2-sulfatase enzyme with a novel single-stranded RNA virus vector.
    Ohira M; Kikuchi E; Mizuta S; Yoshida N; Onodera M; Nakanishi M; Okuyama T; Mashima R
    Genes Cells; 2021 Nov; 26(11):891-904. PubMed ID: 34480399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel iduronate 2-sulfatase mutation in a Chinese family with mucopolysaccharidosis type II.
    Li XY; Shi XY; Ju J; Hu XH; Yang XF; Zou LP
    World J Pediatr; 2012 Aug; 8(3):281-3. PubMed ID: 22622771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.